TS
Tsuruha Holdings Inc.
TSUSF · OTC
$17.25 +0.00% (+$0.00)
Market Cap ¥647.9B
P/E Ratio 15.14x
Div. Yield 1.74%
ROE 7.28%
Bulios Fair Price
$23.65
37.1% upside
Current Price
$17.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TSUSF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/E 15.14x
PEG 0.16x
EV/EBITDA 6.96x
Growth
87 /100
Growing EPS growth 17.21%
Book val. growth 46.11%
Rev. growth 14.46%
Profitability
31 /100
Weak Gross margin 30.61%
FCF margin 4.11%
Net margin 2.94%
Quality
32 /100
Poor ROIC 3.74%
Asset turnover 0.88x
ROE 7.28%
Debt
93 /100
Low Debt/Equity 0.24x
Net debt/EBITDA 0.07x
Current ratio 1.24x
Stability
34 /100
Moderate Beta 0.18x
Profitable years 6
Rev. volatility 17.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TSUSF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jun Tsuruha
Employees
27,681
Headquarters
Sapporo
Upcoming events
12 OCT
Earnings
Upcoming earnings report
22 DEC
Earnings
Upcoming earnings report
25 FEB
Ex-Dividend
Ex-dividend date
25 FEB
Dividend Payment
Payment date